Holen Sie sich die Stockscreener-App
44.16
2.60%
1.12
Handel nachbörslich:
44.16
Schlusskurs vom Vortag:
$43.04
Offen:
$42.78
24-Stunden-Volumen:
2.43M
Relative Volume:
2.06
Marktkapitalisierung:
$4.15B
Einnahmen:
$3.20B
Nettoeinkommen (Verlust:
$245.10M
KGV:
20.34
EPS:
2.1709
Netto-Cashflow:
$505.23M
1W Leistung:
-8.74%
1M Leistung:
-19.40%
6M Leistung:
-22.10%
1J Leistung:
-3.98%
1-Tages-Spanne:
$42.17
$44.27
1-Wochen-Bereich:
$40.57
$48.71
52-Wochen-Spanne:
$31.97
$58.75
Lazard Inc Stock (LAZ) Company Profile
Firmenname
Lazard Inc
Sektor
Branche
Telefon
(212) 632-6000
Adresse
30 ROCKEFELLER PLAZA, NEW YORK
Compare LAZ vs MS, GS, SCHW, HOOD, IBKR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAZ
Lazard Inc
|
44.16 | 4.04B | 3.20B | 245.10M | 505.23M | 2.1709 |
|
MS
Morgan Stanley
|
160.89 | 255.25B | 119.71B | 17.03B | 46.10B | 10.21 |
|
GS
Goldman Sachs Group Inc
|
823.76 | 247.44B | 126.15B | 17.18B | 23.15B | 51.30 |
|
SCHW
Charles Schwab Corp
|
92.67 | 163.25B | 27.68B | 8.85B | 13.27B | 4.6601 |
|
HOOD
Robinhood Markets Inc
|
78.69 | 70.70B | 4.51B | 1.88B | -3.42B | 2.059 |
|
IBKR
Interactive Brokers Group Inc
|
68.39 | 30.51B | 10.43B | 4.36B | 24.23B | 2.2152 |
Lazard Inc Stock (LAZ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-26 | Eingeleitet | BofA Securities | Buy |
| 2025-12-11 | Fortgesetzt | UBS | Neutral |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-08-25 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2025-04-07 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-03 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-20 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-12-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-09-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-01-29 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2024-01-03 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-09-19 | Herabstufung | Goldman | Neutral → Sell |
| 2023-07-13 | Hochstufung | Keefe Bruyette | Underperform → Mkt Perform |
| 2023-07-12 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-07-03 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2023-04-12 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-07-18 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-07-13 | Herabstufung | Keefe Bruyette | Mkt Perform → Underperform |
| 2022-04-07 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2022-03-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-04 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-10-01 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2021-04-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-14 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2020-12-16 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-12-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-10-02 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-06-23 | Eingeleitet | Credit Suisse | Neutral |
| 2020-04-24 | Herabstufung | CFRA | Hold → Sell |
| 2020-03-25 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-01-27 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-06-10 | Herabstufung | UBS | Buy → Neutral |
| 2019-04-11 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-01-04 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
| 2018-11-06 | Eingeleitet | Goldman | Neutral |
| 2018-04-17 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-01-03 | Hochstufung | Nomura | Neutral → Buy |
| 2017-12-21 | Herabstufung | Buckingham Research | Buy → Neutral |
| 2017-03-23 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2017-02-17 | Eingeleitet | Keefe Bruyette | Outperform |
| 2017-02-03 | Bestätigt | UBS | Buy |
| 2017-01-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
Alle ansehen
Lazard Inc Aktie (LAZ) Neueste Nachrichten
Lazard’s assets under management increased by 4% in February, driven by positive net inflows and market appreciation. - Bitget
Lazard's February AUM Rises 4% on Net Inflows & Market Gains - TradingView
Is Lazard (LAZ) Attractive After Recent Share Price Weakness And Valuation Gap? - simplywall.st
Lazard (LAZ) Announces February AUM at $277.7 Billion - GuruFocus
Lazard Posts $277.74 Billion Preliminary Assets Under Management for February - marketscreener.com
Lazard reports assets under management rise to $277.7 billion - Investing.com
Lazard Reports February 2026 Assets Under Management - PR Newswire
LAZARD INC (NYSE:LAZ): A High-Yield Dividend Stock Worth a Closer Look - ChartMill
Lazard (NYSE:LAZ) Shares Down 8.2%Should You Sell? - MarketBeat
Perella Weinberg, Franklin Resources, Moelis, Lazard, and PROG Shares Plummet, What You Need To Know - Yahoo Finance
Lazard Inc (LAZ) Trading Down 7.12% on Mar 9 - GuruFocus
Fundamentals Check: Is Lazard Inc a strong candidate for buy and holdPortfolio Return Report & Accurate Intraday Trading Signals - baoquankhu1.vn
Crossmark Global Holdings Inc. Purchases New Stake in Lazard, Inc. $LAZ - MarketBeat
Piper Sandler, Moelis, Lazard, Evercore, and Corpay Stocks Trade Down, What You Need To Know - Yahoo Finance
Options Flow: What makes Lazard Inc stock attractive today2025 Top Decliners & Growth Oriented Trade Recommendations - baoquankhu1.vn
3 Lazard Mutual Funds Worth Considering for a Strong Portfolio - Bitget
3 Lazard Mutual Funds That You May Buy to Build a Solid Portfolio - TradingView
Lazard Adds Senior Healthcare Leaders As Shares Screen Undervalued - Sahm
Lazard U.S. Convertibles Portfolio Q4 2025 Commentary - Seeking Alpha
Lazard, Inc. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
BEN's February AUM Rises on Positive Markets: Will the Upside Last? - TradingView
Victory Capital Management Inc. Decreases Holdings in Lazard, Inc. $LAZ - MarketBeat
Lazard, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Indicators - Markets Mojo
Institution Moves: Can Lazard Inc sustain earnings growthWeekly Stock Recap & Weekly High Return Stock Opportunities - baoquankhu1.vn
Lazard Adds Allen And Co Veterans To Build Healthcare Deal Advisory - Yahoo Finance
Can Lazard Inc. reach all time highs this year2025 Price Targets & Community Consensus Trade Signals - mfd.ru
Lazard Opportunistic Strategies Portfolio Q4 2025 Commentary (Mutual Fund:LCAIX) - Seeking Alpha
Lazard, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics - Markets Mojo
Fisher Asset Management LLC Boosts Stock Holdings in Lazard, Inc. $LAZ - MarketBeat
BREAKINGVIEWS-Boutique bank deal champions long-term greed - Sahm
Royce & Associates LP Reduces Stock Position in Lazard, Inc. $LAZ - MarketBeat
Assessing Lazard (LAZ) Valuation After Profitability Squeeze And Insider Selling - Sahm
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in January - Sahm
Tounjian Advisory Partners LLC Purchases New Holdings in Lazard, Inc. $LAZ - MarketBeat
Lazard (NYSE:LAZ) Upgraded by Wall Street Zen to Buy Rating - MarketBeat
Why Lazard (LAZ) Stock Is Down Today - Yahoo Finance
Lazard Global Total Return and Income Fund, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Lazard International Strategic Equity Portfolio Q4 2025 Commentary (Mutual Fund:LZIEX) - Seeking Alpha
Lazard Veteran to Launch Hedge Fund for EM Bets at Bramshill - Bloomberg.com
Lazard, Inc. (NYSE:LAZ) Given Average Rating of "Hold" by Analysts - MarketBeat
AI Adoption Poses Growing Operational, Regulatory and Cyber Risks for Lazard Ltd. - The Globe and Mail
New Healthcare Hires And Margin Pressure Might Change The Case For Investing In Lazard (LAZ) - simplywall.st
Vanguard Group Inc. Boosts Stake in Lazard, Inc. $LAZ - MarketBeat
Lazard, Inc. Common Stock (NY: LAZ - The Chronicle-Journal
Lazard International Equity Select Portfolio Q4 2025 Commentary - Seeking Alpha
Envestnet Asset Management Inc. Has $4.34 Million Stake in Lazard, Inc. $LAZ - MarketBeat
Decoding Lazard Inc (LAZ): A Strategic SWOT Insight - GuruFocus
Does Lazard (LAZ) Offer Value After Recent Share Price Softness? - Yahoo Finance
LAZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Lazard (LAZ) COO Alexandra Soto acquires 2,553 RSUs with staged vesting - Stock Titan
Lazard (LAZ) CAO Michael Gathy receives 92 new RSUs in grant - Stock Titan
Finanzdaten der Lazard Inc-Aktie (LAZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):